These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 33037574

  • 1. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
    Lin ZH, Jiang JR, Ma XK, Chen J, Li HP, Li X, Wu XY, Huang MS, Lin Q.
    Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of recurrence for serum hypoxia inducible factor-1α C-reaction protein in hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
    Jing Q, Jianyong L, Jiming Y, Shuren L, Rui W, Wei L.
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e105-6. PubMed ID: 26728665
    [Abstract] [Full Text] [Related]

  • 3. HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Pinto E, Pelizzaro F, Cardin R, Battistel M, Palano G, Bertellini F, Kitenge MP, Peserico G, Farinati F, Russo FP.
    Dig Liver Dis; 2024 May; 56(5):872-879. PubMed ID: 37783655
    [Abstract] [Full Text] [Related]

  • 4. Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma.
    Xu W, Kwon JH, Moon YH, Kim YB, Yu YS, Lee N, Choi KY, Kim YS, Park YK, Kim BW, Wang HJ.
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1507-15. PubMed ID: 24853275
    [Abstract] [Full Text] [Related]

  • 5. [Correlations between serum hypoxia inducible factor-1α, vascular endothelial growth factor and computed tomography perfusion imaging at pre-and post-TACE in patients with primary hepatic carcinoma].
    Jia ZZ, Huang YQ, Feng YL, Jiang GM.
    Zhonghua Yi Xue Za Zhi; 2013 May 21; 93(19):1472-5. PubMed ID: 24029570
    [Abstract] [Full Text] [Related]

  • 6. Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer.
    Jia ZZ, Jiang GM, Feng YL.
    Chin Med Sci J; 2011 Sep 21; 26(3):158-62. PubMed ID: 22207924
    [Abstract] [Full Text] [Related]

  • 7. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
    Huang M, Wang L, Chen J, Bai M, Zhou C, Liu S, Lin Q.
    Int J Oncol; 2016 May 21; 48(5):2144-54. PubMed ID: 26984380
    [Abstract] [Full Text] [Related]

  • 8. Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Wu Y, Fan W, Xue M, Zhong B, Zhang S, Wang Y, Yao W, Zhao Y, Li J.
    Oncologist; 2019 Dec 21; 24(12):e1489-e1495. PubMed ID: 31249138
    [Abstract] [Full Text] [Related]

  • 9. Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients.
    Shim JH, Park JW, Kim JH, An M, Kong SY, Nam BH, Choi JI, Kim HB, Lee WJ, Kim CM.
    Cancer Sci; 2008 Oct 21; 99(10):2037-44. PubMed ID: 19016764
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.
    Kim SS, Cho HJ, Won JH, Bae JI, Kang DR, Lee JD, Shin SJ, Lee KM, Yoo BM, Kim JK, Lee JH, Ahn SJ, Park JH, Cho SW, Cheong JY.
    Cytokine; 2015 Dec 21; 76(2):449-457. PubMed ID: 26163999
    [Abstract] [Full Text] [Related]

  • 11. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY, Lin ZY, Chuang WL.
    Kaohsiung J Med Sci; 2011 Aug 21; 27(8):314-22. PubMed ID: 21802642
    [Abstract] [Full Text] [Related]

  • 12. Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization.
    Guo M, Qi F, Rao Q, Sun J, Du X, Qi Z, Yang B, Xia J.
    Front Immunol; 2021 Aug 21; 12():754961. PubMed ID: 34691076
    [Abstract] [Full Text] [Related]

  • 13. 25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.
    Wu YQ, Fan WZ, Xue M, Guo J, Wei JL, Wang Y, Yao W, Zhao Y, Li JP.
    Clin Transl Oncol; 2020 Jan 21; 22(1):70-80. PubMed ID: 31183764
    [Abstract] [Full Text] [Related]

  • 14. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
    Qu K, Yan Z, Wu Y, Chen Y, Qu P, Xu X, Yuan P, Huang X, Xing J, Zhang H, Liu C, Zhang J.
    J Gastroenterol Hepatol; 2015 May 21; 30(5):925-32. PubMed ID: 25641377
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR, Tian MX, Tao CY, Tang Z, Zhou YF, Song SS, Jiang XF, Wang H, Zhou PY, Qu WF, Fang Y, Ding ZB, Zhou J, Fan J, Shi YH.
    BMC Cancer; 2020 Jul 10; 20(1):642. PubMed ID: 32650743
    [Abstract] [Full Text] [Related]

  • 17. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
    Liu S, Li H, Guo L, Zhang B, Zhou B, Zhang W, Zhou J, Fan J, Ye Q.
    Oncologist; 2019 Apr 10; 24(4):513-520. PubMed ID: 30552155
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients.
    Ranieri G, Ammendola M, Marech I, Laterza A, Abbate I, Oakley C, Vacca A, Sacco R, Gadaleta CD.
    World J Gastroenterol; 2015 May 21; 21(19):6018-25. PubMed ID: 26019468
    [Abstract] [Full Text] [Related]

  • 19. β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization.
    Xu X, Gao D, Yuan X, Liu LI, Zhang X, Liang X, Chen S, Ai M, Chen BO, Shi D, Yang Z, Hoffman RM, Xu J.
    Anticancer Res; 2019 Mar 21; 39(3):1129-1134. PubMed ID: 30842141
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of serum vascular endothelial growth factor receptor 2 response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Zheng YB, Meng QW, Zhao W, Liu B, Huang JW, He X, Li Y, Hu BS, Lu LG.
    Med Oncol; 2014 Mar 21; 31(3):843. PubMed ID: 24442426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.